Enmetazobactam
Showing 1 - 5 of 5
Complicated Urinary Tract Infection Trial in Worldwide (cefepime and enmetazobactam combination)
Not yet recruiting
- Complicated Urinary Tract Infection
- cefepime and enmetazobactam combination
-
Hradec Králové, Czechia
- +5 more
Apr 21, 2023
Healthy Trial in Baltimore (1 µCi of 14C-AAI101 + 500 mg AAI101)
Completed
- Healthy
- 1 µCi of 14C-AAI101 + 500 mg AAI101
-
Baltimore, MarylandPharmaron Clinical Pharmacology Center
Feb 25, 2019
PK in Patients With Various Degrees of Renal Impairment Trial in Praha, Budapest (cefepime/AAI101)
Unknown status
- PK in Patients With Various Degrees of Renal Impairment
-
Praha, Jankovcova, Czechia
- +1 more
Sep 21, 2018
Urinary Tract Infections Trial in Worldwide (Cefepime 1G - 2G / AAI101 0.5G - 0.75G, cefepime 1 g or cefepime 2 g)
Completed
- Urinary Tract Infections
- Cefepime 1G - 2G / AAI101 0.5G - 0.75G
- cefepime 1 g or cefepime 2 g
-
Kromeriz, Czechia
- +4 more
Sep 20, 2018
Healthy Trial (AAI101 i.v., Saline 0.9% infusion, Piperacillin i.v.)
Completed
- Healthy
- AAI101 i.v.
- +3 more
- (no location specified)
Sep 25, 2018